Irsenontrine

Overview

Irsenontrine (E2027) is an orally active and selective phosphodiesterase 9 ( PDE9 ) inhibitor. Irsenontrine can be used for the research of neurological diseases.

Application

Products | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE)

Product Information

• Catalog No.: HY-132821
• CAS No.: 1429509-82-9
• Molecular Formula: C22H22N4O3
• Molecular Weight: 390.44
• Purity: 99.91%
• Storage: 4°C, sealed storage, away from moisture and light * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
• Solubility: ≥ 1.25 mg/mL (3.20 mM); Suspended solution
• Availability: In-stock

Source

Original product source